• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性关节炎治疗进展。

Advances in the treatment of inflammatory arthritis.

机构信息

Medical Research Service, Durham VA Hospital, NC 27705, USA.

出版信息

Best Pract Res Clin Rheumatol. 2012 Apr;26(2):251-61. doi: 10.1016/j.berh.2012.03.001.

DOI:10.1016/j.berh.2012.03.001
PMID:22794097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3461328/
Abstract

The inflammatory arthritides are a diverse group of conditions characterised by joint inflammation which can lead to pain, deformity and disability. Of these diseases, rheumatoid arthritis (RA) and spondyloarthritis are two of the most common. While the clinical and demographic features of these diseases differ, the central role of inflammation in their pathogenesis has allowed the development of highly effective treatment strategies with wide applicability. These strategies include the use of biological agents which target the cytokine tumour necrosis factor (TNF), a key mediator of inflammation. With the advent of effective agents, therapy has become more aggressive, reducing disease activity and allowing, at least in RA, remission in many patients. While the array of available effective treatments is extensive, the use of objective measures of disease activity can guide treatment decisions (treat to target) and lead to improved outcomes.

摘要

炎症性关节炎是一组具有关节炎症特征的疾病,可导致疼痛、畸形和残疾。在这些疾病中,类风湿关节炎(RA)和脊柱关节炎是最常见的两种。虽然这些疾病的临床和人口统计学特征不同,但炎症在发病机制中的核心作用使得开发出了具有广泛适用性的高效治疗策略成为可能。这些策略包括使用靶向细胞因子肿瘤坏死因子(TNF)的生物制剂,TNF 是炎症的关键介质。随着有效药物的出现,治疗变得更加积极,降低了疾病活动度,使许多患者至少在 RA 中能够缓解。虽然现有的有效治疗方法很多,但使用疾病活动的客观指标可以指导治疗决策(针对目标治疗)并改善结果。

相似文献

1
Advances in the treatment of inflammatory arthritis.炎症性关节炎治疗进展。
Best Pract Res Clin Rheumatol. 2012 Apr;26(2):251-61. doi: 10.1016/j.berh.2012.03.001.
2
Biologic agents in rheumatoid arthritis: an update for managed care professionals.类风湿关节炎中的生物制剂:给管理式医疗专业人员的最新资讯
J Manag Care Pharm. 2011 Nov-Dec;17(9 Suppl B):S14-8. doi: 10.18553/jmcp.2011.17.s9-b.S14.
3
Diagnosis and Management of Rheumatoid Arthritis: A Review.类风湿关节炎的诊断与治疗:综述。
JAMA. 2018 Oct 2;320(13):1360-1372. doi: 10.1001/jama.2018.13103.
4
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?类风湿关节炎和银屑病关节炎患者在临床及超声缓解期接受抗TNF治疗时的滑膜特征存在差异:这是否是解释临床缓解后复发几率不同的线索?
Ann Rheum Dis. 2017 Jul;76(7):1228-1236. doi: 10.1136/annrheumdis-2016-210424. Epub 2017 Jan 24.
5
Differing local and systemic inflammatory burden in polyarticular psoriatic arthritis and rheumatoid arthritis patients on anti-TNF treatment in clinical remission.临床缓解期接受抗TNF治疗的多关节型银屑病关节炎和类风湿关节炎患者的局部和全身炎症负担存在差异。
Clin Exp Rheumatol. 2017 Jan-Feb;35(1):74-79. Epub 2016 Oct 7.
6
Drug therapy of inflammatory arthritis.炎症性关节炎的药物治疗。
Clin Med (Lond). 2012 Aug;12(4):357-63. doi: 10.7861/clinmedicine.12-4-357.
7
Targeting inflammation in the prevention of cardiovascular disease in patients with inflammatory arthritis.针对炎症预防炎症性关节炎患者的心血管疾病
Transl Res. 2016 Jan;167(1):138-51. doi: 10.1016/j.trsl.2015.05.006. Epub 2015 May 16.
8
Strategies toward rheumatoid arthritis therapy; the old and the new.类风湿关节炎治疗策略:旧与新。
J Cell Physiol. 2019 Jul;234(7):10018-10031. doi: 10.1002/jcp.27860. Epub 2018 Dec 7.
9
Randomised controlled trial of tumour necrosis factor inhibitors against combination intensive therapy with conventional disease-modifying antirheumatic drugs in established rheumatoid arthritis: the TACIT trial and associated systematic reviews.肿瘤坏死因子抑制剂对比传统改善病情抗风湿药物联合强化治疗用于确诊类风湿关节炎的随机对照试验:TACIT试验及相关系统评价
Health Technol Assess. 2014 Oct;18(66):i-xxiv, 1-164. doi: 10.3310/hta18660.
10
Advances in use of immunomodulatory agents--a rheumatology perspective.免疫调节剂的应用进展——风湿病学视角。
Nat Rev Gastroenterol Hepatol. 2015 Jun;12(6):363-8. doi: 10.1038/nrgastro.2015.65. Epub 2015 Apr 21.

引用本文的文献

1
The prognostic implications of comorbidities in septic arthritis.脓毒性关节炎中共病的预后意义。
Front Med (Lausanne). 2025 Jul 29;12:1566384. doi: 10.3389/fmed.2025.1566384. eCollection 2025.
2
Photobiomodulation control the expression of MMP, TNF-α and NK-1 receptors, improving allodynia and cartilage resistance in rheumatoid arthritis model.光生物调节可控制基质金属蛋白酶、肿瘤坏死因子-α和神经激肽-1受体的表达,改善类风湿性关节炎模型中的痛觉过敏和软骨抵抗力。
Lasers Med Sci. 2025 Jul 1;40(1):306. doi: 10.1007/s10103-025-04557-x.
3
Use of DCE-MRI in arthritis in the appendicular skeleton: a narrative review.DCE-MRI在四肢骨骼关节炎中的应用:一项叙述性综述。
Skeletal Radiol. 2025 Jun 10. doi: 10.1007/s00256-025-04966-7.
4
Radiation Synovectomy: An Enticing Treatment Option for Inflammatory Joint Pain.放射性滑膜切除术:炎性关节疼痛的一种诱人治疗选择。
Pain Res Manag. 2025 May 13;2025:8887391. doi: 10.1155/prm/8887391. eCollection 2025.
5
The impact of biosimilar use on healthcare utilization among new users of etanercept for inflammatory arthritis: a population-based regression discontinuity analysis.生物类似药使用对炎症性关节炎新使用依那西普患者医疗保健利用的影响:基于人群的断点回归分析
Lancet Reg Health Am. 2025 Apr 11;45:101058. doi: 10.1016/j.lana.2025.101058. eCollection 2025 May.
6
Association of human blood metabolites with rheumatoid arthritis: A Mendelian randomization study.人类血液代谢物与类风湿性关节炎的关联:一项孟德尔随机化研究。
Medicine (Baltimore). 2025 Mar 7;104(10):e41666. doi: 10.1097/MD.0000000000041666.
7
Anti-arthritic and immunomodulatory efficacy of Micromeria biflora Benth extract and its fractions in rats by restoring oxidative stress, metalloproteinases, pro-inflammatory and anti-inflammatory cytokines network.密花香薷提取物及其各馏分通过恢复氧化应激、金属蛋白酶、促炎和抗炎细胞因子网络对大鼠的抗关节炎和免疫调节作用。
Inflammopharmacology. 2024 Aug;32(4):2477-2491. doi: 10.1007/s10787-024-01479-y. Epub 2024 May 8.
8
Hesperidin Attenuates Titanium Dioxide Nanoparticle-Induced Neurotoxicity in Rats by Regulating Nrf-2/TNF-α Signaling Pathway, the Suppression of Oxidative Stress, and Inflammation.橙皮苷通过调节Nrf-2/TNF-α信号通路、抑制氧化应激和炎症来减轻二氧化钛纳米颗粒诱导的大鼠神经毒性。
ACS Omega. 2023 Sep 25;8(40):37584-37591. doi: 10.1021/acsomega.3c06198. eCollection 2023 Oct 10.
9
Revisiting p38 Mitogen-Activated Protein Kinases (MAPK) in Inflammatory Arthritis: A Narrative of the Emergence of MAPK-Activated Protein Kinase Inhibitors (MK2i).重新审视炎症性关节炎中的p38丝裂原活化蛋白激酶(MAPK):MAPK活化蛋白激酶抑制剂(MK2i)的出现历程
Pharmaceuticals (Basel). 2023 Sep 12;16(9):1286. doi: 10.3390/ph16091286.
10
Medicinal cannabis for Australian patients with chronic refractory pain including arthritis.医用大麻用于患有包括关节炎在内的慢性顽固性疼痛的澳大利亚患者。
Br J Pain. 2023 Apr;17(2):206-217. doi: 10.1177/20494637221147115. Epub 2022 Dec 20.

本文引用的文献

1
American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.美国风湿病学会/欧洲抗风湿病联盟类风湿关节炎临床试验缓解的临时定义。
Ann Rheum Dis. 2011 Mar;70(3):404-13. doi: 10.1136/ard.2011.149765.
2
Comparison of the efficacy of sonography, magnetic resonance imaging and conventional radiography for the detection of bone erosions in rheumatoid arthritis patients: a systematic review and meta-analysis.超声、磁共振成像和常规 X 线摄影检测类风湿关节炎患者骨侵蚀的疗效比较:系统评价和荟萃分析。
Rheumatology (Oxford). 2011 Jun;50(6):1137-47. doi: 10.1093/rheumatology/keq437. Epub 2011 Jan 28.
3
Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke.吸烟是类风湿关节炎的一个主要可预防的风险因素:各种吸烟暴露后风险的估计。
Ann Rheum Dis. 2011 Mar;70(3):508-11. doi: 10.1136/ard.2009.120899. Epub 2010 Dec 13.
4
Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis.类风湿关节炎中糖皮质激素与 DMARD 联合治疗的现状。
Nat Rev Rheumatol. 2010 Dec;6(12):693-702. doi: 10.1038/nrrheum.2010.179.
5
The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.强直性脊柱炎国际评估协会分类标准:外周型脊柱关节炎和一般型脊柱关节炎。
Ann Rheum Dis. 2011 Jan;70(1):25-31. doi: 10.1136/ard.2010.133645. Epub 2010 Nov 24.
6
Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives.类风湿关节炎的心血管疾病:现状与未来展望。
Ann Rheum Dis. 2011 Jan;70(1):8-14. doi: 10.1136/ard.2010.142133. Epub 2010 Nov 24.
7
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.全基因组荟萃分析将确认的克罗恩病易感性位点数量增加到 71 个。
Nat Genet. 2010 Dec;42(12):1118-25. doi: 10.1038/ng.717.
8
Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study.在持续临床缓解的类风湿关节炎患者中停止治疗:BeSt 研究的探索性分析。
Ann Rheum Dis. 2011 Feb;70(2):315-9. doi: 10.1136/ard.2010.136556. Epub 2010 Nov 10.
9
Cutting edge: A critical functional role for IL-23 in psoriasis.前沿:IL-23 在银屑病中的关键功能作用。
J Immunol. 2010 Nov 15;185(10):5688-91. doi: 10.4049/jimmunol.1001538. Epub 2010 Oct 18.
10
A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.一项全基因组关联研究确定了新的银屑病易感基因座和 HLA-C 与 ERAP1 之间的相互作用。
Nat Genet. 2010 Nov;42(11):985-90. doi: 10.1038/ng.694. Epub 2010 Oct 17.